.png)
The right transfusion, always, everywhere.
Full members
Simon Stanworth, NHS Blood and Transplant and Oxford University, United Kingdom (ICTMG Chair)
Katerina Pavenski, St. Michael's Hospital and University of Toronto, Canada (ICTMG Vice Chair)
Arwa Z. Al-Riyami, Sultan Qaboos University Hospital, Oman
Shubha Allard, NHS Blood and Transplant, United Kingdom
Melissa Brouwers, University of Ottawa, Canada
Jeannie Callum, Kingston Health Sciences Centre and Queen's University, Canada
James Daly, Australian Red Cross Blood Services, Australia
Greg Denomme, Grifols Laboratory Solutions, United States
Lise Estcourt, NHS Blood & Transplant, United Kingdom
Dean Fergusson, Ottawa Hospital Research Institute, Canada
Mark Fung, University of Vermont Medical Centre, United States
Laura Green, NHS Blood and Transplant and Barts Health Trust, United Kingdom
Andreas Greinacher, University of Greifswald, Germany
Heather Hume, University of Montreal, Canada
Rachel Jug, University of Cincinnati Medical Center, United States
Richard Kaufman, Brigham & Woman's Hospital Transfusion Service, United States
Hyungsuk Kim, Seoul National University Hospital and Seoul National University College
of Medicine, Korea
Ursula La Rocca, Sapienza University of Rome and Italian National Blood Center, Italy
Lani Lieberman, University Health Network and Sunnybrook Health Centre, Canada
Vernon Louw, Groote Schuur Hospital and University of Cape Town, South Africa
Tadashi Matsushita, Nagoya University Hospital, Japan
Michael Murphy, University of Oxford, United Kingdom
Susan Nahirniak, Alberta Public Laboratories and University of Alberta, Canada
Joanne Pink, Australian Red Cross Blood Services, Australia
Susan Robinson, Guy's and St. Thomas' NHS Foundation Trust, United Kingdom
Nadine Shehata, Mount Sinai Hospital, Toronto, Canada
Cynthia So-Osman, Sanquin and Erasmus Medical Center, The Netherlands
Zbigniew M. Szczepiorkowski, Dartmouth-Hitchcock Medical Center, United States
Aaron Tobian, John Hopkins University, United States
Erica Wood, Monash University, Australia
Simon Stanworth, MA, FRCP (Paeds, UK), PhD, FRCPath
NHS Blood and Transplant and Oxford University
United Kingdom
Expertise: Prof. Stanworth is a consultant hematologist and honorary senior clinical lecturer at the University of Oxford. His research centers on clinical indications of blood transfusion components through systematic reviews and clinical studies. Please view Prof. Stanworth’s publications here.
ICTMG connections: Prof. Stanworth is the ICTMG executive chair (2021-present). He is co-chair of the Methods Committee, and a member of the Executive, Topics Selection, and Editorial committees. He is also the co-chair for the guideline development group for platelets.
Katerina Pavenski, MD, FRCPC
St. Michael's Hospital and University of Toronto
Canada
Expertise: Dr. Pavenski is clinical hematologist and head of the division of transfusion medicine at St. Michael’s Hospital in Toronto. She is an associate professor in the Departments of Laboratory Medicine & Pathobiology and Medicine, University of Toronto. Her research interests include clinical transfusion medicine, transfusion management of massive hemorrhage, and patient blood management. Please find Dr. Pavenski’s publications here.
ICTMG connections: Dr. Pavenski is ICTMG executive vice-chair (2021-present). She is co-chair of the Topics Selection Committee and a member of the Executive and the Dissemination and Implementation committees. She is also a member of the guideline development group for platelets.
Arwa Z. Al-Riyami, BSc, MD, FRCPc, @DrRiyamia
Sultan Qaboos University Hospital
Oman
Expertise: Dr. Al-Riyami is a senior consultant hematopathologist. Her research centres on clinical transfusion, blood banking, and medical education. Please view Dr. Al-Riyami's publications here.
ICTMG Connections: Dr. Al-Riyami is a member of the Topics Selection Committee.
Shubha Allard, MD, FRCP, FRCPath
National Health Service Blood & Transplant
United Kingdom
Expertise: Dr. Allard is a consultant hematologist with a research interest in appropriate use of blood and blood components. Please view Dr. Allard’s publications here.
ICTMG connections: Dr. Allard is a member of the Topics Selection Committee, the Dissemination and Implementation Committee, and the guideline development group for platelets
Melissa Brouwers, PhD
University of Ottawa
Canada
Expertise: Dr. Brouwers is a health sciences researcher with an interest in knowledge translation, implementation science and evaluation and director of the School of Epidemiology and Public Health at the University of Ottawa. Please view Dr. Brouwers' publications here.
ICTMG connections: Dr. Brouwers is a member of the Methods Committee
Jeannie Callum, MD, FRCPC, @JeannieCallum
Kingston Health Sciences Centre and Queen's University
Canada
Expertise: Dr. Callum is a transfusion medicine specialist and hematologist. Her research investigates the management of major hemorrhage, transfusion-related errors, and adverse consequences of transfusion. Please view Dr. Callum's publications here.
ICTMG connections: Dr. Callum is a member of the Dissemination and Implementation Committee, a member of the guideline development group for platelets, and the co-chair of the guideline development group for albumin.
James Daly, MBBS, FRACP, FRCPA
Australian Red Cross Lifeblood
Australia
Expertise: Dr. Daly is a clinical and laboratory haematologist and medical director of pathology services at Australian Red Cross Lifeblood. Please view Dr. Daly's publications here.
ICTMG connections: Dr. Daly is the co-chair of the Dissemination and Implementation Committee and a member of the Executive and the Editorial committees.
Greg Denomme, PhD, FCSMLS(D), @GregDenomme
Grifols Laboratory Solutions
United States
Expertise: Dr. Denomme is a clinical and academic trained scientist. His research examines the molecular basis of blood group antigens and the application of molecular immunohematology in the diagnosis of immune-mediated hemolytic anemia. Please view Dr. Denomme’s publications here.
ICTMG connections: Dr. Denomme is a member of the Topics Selection Committee, and a member of the guideline development group for hemoglobinopathies.
Lise Estcourt, MB BChir, MA(Cantab), MA(MEL), MSc, DLSHTM, DPhil, MRCP, FRCPath, @AndelLestcourt
National Health Service Blood & Transplant
United Kingdom
Expertise: Dr. Estcourt is a consultant hematologist. Her research focuses on the safe and effective use of blood components in patients with hematological disorders. Please view Dr. Estcourt’s publications here.
ICTMG connections: Dr. Escourt is a member of the Methods Committee, and a member of the guideline development group for platelets.
Dean Fergusson, PhD, MHA
Ottawa Hospital Research Institute
Canada
Expertise: Dr. Fergusson is a senior scientist and director of the clinical epidemiology program at the Ottawa Hospital Research Institute. His clinical research interest are mainly in the field of transfusion medicine with a focus on transfusion alternatives and the effectiveness of blood products. Please view Dr. Fergusson’s publications here.
ICTMG connections: Dr. Fergusson is co-chair of the Methods Committee, and a member of the Executive and the Editorial committees. He is also a member of the guideline development group for platelets.
Mark Fung, MD, PhD, @MarkFungMDPhD
University of Vermont Medical Center
United States
Expertise: Dr. Fung is a pathologist with expertise in transfusion medicine and HLA. His research interests include transfusion medicine/blood banking and HLA platelet compatibility. Please view Dr. Fung’s publications here.
ICTMG connections: Dr. Fung is the co-chair of the Editorial Committee, and a member of the Executive, Topics Selection, and Dissemination and Implementation committees. He is also a member of the guideline development group for platelets.
Laura Green, MBBS, MD (Res), FRCP, FRCPath
NHS Blood and Transplant
United Kingdom
Expertise: Dr. Green is a consultant hematologist with joint appointments at NHS Blood and Transplant, and Barts Health Trust. Her research focuses on improving transfusion management of bleeding patients.
ICTMG connections: Dr. Green is a member of the Editorial Committee.
University of Greifswald
Germany
Expertise: Dr. Greinacher is a transfusion medicine specialist. His research interests include hereditary and immune mediated thrombocytopenias, especially heparin-induced thrombocytopenia. Please view Dr. Greinacher’s publications here.
ICTMG connections: Dr. Greinacher is a member of the Editorial and the Topics Selection committees, the co-chair of the guideline development group for fetal/neonatal alloimmune thrombocytopenia (FNAIT) and a member of the guideline development group for platelets.
Heather Hume, MD, FRCPC, MSc
University of Montreal
Canada
Expertise: Dr. Hume is a pediatric hematologist with a clinical research interest in non-malignant pediatric hematology and transfusion medicine. Please view Dr. Hume’s publications here.
ICTMG connections: Dr. Hume is a member of the Dissemination and Implementation and the Topics Selection committees. She is a member of the guideline development groups for fetal/neonatal alloimmune thrombocytopenia (FNAIT) and platelets.
Rachel Jug, MB, BCh, BAO
University of Cincinnati Medical Center
United States
Expertise: Dr. Jug is an assistant professor of pathology and laboratory medicine with a research interest in transfusion medicine, anatomical and clinical pathology and medical education.
ICTMG connections: Dr. Jug is a member of the Dissemination and Implementation and the Topics Selection Committee. She is a member of the Guideline Development Group for the platelet AGREE II systematic review.
Richard Kaufman, MD, @RichardMKaufman
Brigham & Women's Hospital Adult Transfusion Service
United States
Expertise: Dr. Kaufman is medical director of the blood bank and transfusion service at the Brigham and Women’s Hospital in Boston and associate professor of pathology at Harvard Medical School. His research interests include blood banking, immunology, peripheral blood stem cell collection and transfusion medicine. Please view Dr. Kaufman’s publications here.
ICTMG connections: Dr. Kaufman is a member of the Editorial Committee.
Hyungsuk Kim, MSc, MD
Seoul National University Hospital and Seoul National University College of Medicine
Korea
Expertise: Dr. Kim is a clinical professor in laboratory medicine at Seoul National University Hospital and Seoul National University College of Medicine. His research interest is mainly in the field of transfusion medicine with a focus on immunohematology. He also works as the Director of Information and Communication of the Korean Society of Blood Transfusion. Please view Dr. Kim’s publications here.
ICTMG connections: Dr. Kim is a member of the Dissemination and Implementation Committee.
Ursula La Rocca, MD
Sapienza University of Rome and Italian National Blood Center
Italy
Expertise: Dr. La Rocca is a hematologist with research interests in immunohematology and transfusion medicine, hematopoietic stem cell transplantation, and pediatric hematology.
ICTMG connections: Dr. La Rocca is a member of the guideline development group for hemolytic disease of the newborn (HDN).
Lani Lieberman, MD, FRCP
University Health Network and Sunnybrook Health Science Centre
Canada
Expertise: Dr. Lieberman is a transfusion medicine specialist and pediatric hematologist. Her research interests are transfusion medicine and benign hematology with a special interest in pediatric transfusion issues.
ICTMG connections: Dr. Lieberman is a member of the Topics Selection Committee, co-chair of the guideline development group for hemolytic disease of the newborn (HDN), and a member of the guideline development group for fetal/neonatal alloimmune thrombocytopenia (FNAIT).
Vernon Louw, MBChB (Stell), MMed(Int Med)(Stell), PhD(HPE)(UFS)
Groote Schuur Hospital, University of Cape Town
South Africa
Expertise: Dr. Louw is a clinical hematologist with interest in research and teaching in transfusion medicine education.
ICTMG connections: Dr. Louw is a member of the Topics Selection Committee and is a member for the guideline development group for platelets.
Tadashi Matsushita
Nagoya University Hospital
Japan
Expertise: Dr. Matsushita is a hematologist with a focus on clinical and basic research of blood coagulation and pathophysiology of thrombogenesis.
Michael Murphy, MD FRCP, FRCPath, FFPath, @MurphyProf
University of Oxford and National Health Service Blood & Transplant
United Kingdom
Expertise: Dr. Murphy is a hematologist with a research interest in patient blood management and the implementation of measures, such as the use of technology, to improve the safety and effectiveness of transfusion practice. Please view Dr. Murphy's publications here.
ICTMG connections: Dr. Murphy is the co-chair of the guideline development group for fetal/neonatal alloimmune thrombocytopenia (FNAIT), and a member of the guideline development group for platelets.
Susan Nahirniak, MD, @SusanNahirniak
Alberta Precision Laboratories and University of Alberta
Canada
Expertise: Dr. Nahirniak is a hematopathologist. Her research interests focus on improving the appropriateness and quality of transfusion medicine. Please find Dr. Nahirniak’s publications here.
ICTMG connections: Dr. Nahirniak is a member of the Topics Selection and the Methods committees and is co-chair of the guideline development group for platelets.
Joanne Pink, MBBS, FRACP, FRCPA, GAICD
Australian Red Cross Lifeblood
Australia
Expertise: Dr. Pink is a hematologist and executive director, clinical services and research/chief medical officer at Australian Red Cross Lifeblood. Her research interests include donor and product safety. Please find Dr. Pink’s publications here.
ICTMG connections: Dr. Pink is a member of the Editorial, Methods, Topics Selection and the Dissemination and Implementation committees. She is also a member of the guideline development group for platelets.
Susan Robinson, MBBS, FRACP, FRCPA, GAICD
Guy's and St. Thomas' NHS Foundation Trust
United Kingdom
Expertise: Dr. Robinson is a consultant hematologist and clinical director. Her research interests include immunohematology, patient blood management, obstetric hematology and transfusion medicine. Please view Dr. Robinson’s publications here.
ICTMG connections: Dr. Robinson is a member of the Topics Selection Committee, and a member of the guideline development groups for platelets and albumin.
Nadine Shehata, MD, MSc, FRCPC
Mount Sinai Hospital, University of Toronto, and Canadian Blood Services
Canada
Expertise: Dr. Shehata is a hematologist. Her research interests are in transfusion medicine as it relates to cardiovascular surgery and maternal fetal medicine, hematological disorders of pregnancy and evidence-based practice guidelines. Please view Dr. Shehata’s publications here.
ICTMG connections: Dr. Shehata is past-chair of ICTMG (2011-2021). She is a member of Methods committee. She is also member of the guideline development groups for platelets, hemolytic disease of the newborn (HDN), and albumin.
Cynthia So-Osman, MD, PhD
Sanquin and Erasmus Medical Center
The Netherlands
Expertise: Dr. So-Osman is a clinical consultant in transfusion medicine and hematology. Her research interests include clinical transfusion medicine, blood management, and evidence-based medicine. Please view Dr. So-Osman’s publications here.
ICTMG connections: Dr. So-Osman is co-chair of the Dissemination and Implementation committee and a member of the Methods Committee.
Zbigniew M. Szczepiorkowski, MD, PhD
Dartmouth-Hitchcock Medical Center
United States
Expertise: Dr. Szczepiorkowski is professor of pathology and laboratory medicine, and medicine. His research interests include novel cellular therapies and an evidence-based approach to the use of therapeutic apheresis in clinical practice. Please view Dr. Szczepiorkowski’s publications here.
ICTMG connections: Dr. Szczepiorkowski is the co-chair of the Editorial Committee, and a member of the Executive, the Methods and the Dissemination and Implementation committees. He is also a member of the guideline development group for platelets.
Aaron Tobian, MD, PhD
Johns Hopkins University
United States
Expertise: Dr. Tobian is director of the transfusion medicine division and professor of pathology, medicine, oncology and epidemiology. His research interests include transfusion transmitted infections and HIV. Please view Dr. Tobian’s publications here.
ICTMG connections: Dr. Tobian is a member of the Editorial and the Topics Selection committees, and is a member of the guideline development group for platelets.
Erica Wood, MBBS, FRACP, FRCPA
Monash University
Australia
Expertise: Dr. Wood is a transfusion medicine specialist and consultant hematologist. Her research interests include hemovigilance and transfusion-transmitted infections. Please view Dr. Wood’s publications here.
ICTMG connections: Dr. wood is the co-chair of the Topics Selection Committee, and a member of the Executive and the Editorial committees. She is also a member of the guideline development groups for hemolytic disease of the newborn (HDN) and platelets.
